GlassScriptPhysician profile
Beverly Bianes Pack
NPI 1285692756
$7,368.36
in general payments reported to CMS, 2019-2025
14 companies · $1,174 in 2025
The $1,174 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $133 · 2021: $908 · 2022: $2,530 · 2023: $1,324 · 2024: $720 · 2025: $1,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,508 · Travel and Lodging: $461 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,507.54 |
| Travel and Lodging | $460.94 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,819.24 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $1,905.32 | 2019-2025 | Precision 1, Dailies Total1, Total30 |
| Bausch & Lomb Americas INC. | $544.94 | 2023-2025 | Miebo, Vyzulta, Xiidra |
| Glaukos Corporation | $444.38 | 2021-2024 | Ce-Marked Kxla System |
| Coopervision INC. | $409.39 | 2022-2025 | Misight Contact Lens, Onefit Contact Lens |
| Ocular Therapeutix, INC. | $384.55 | 2021-2024 | Dextenza |
| Carl Zeiss Meditec, INC. | $250.00 | 2025 | Atlas 500, Cirrus 6000 With Angioplex, Clarus |
| Abbvie INC. | $123.62 | 2022 | |
| Horizon Therapeutics Plc | $123.21 | 2021 | |
| Kala Pharmaceuticals, INC. | $119.35 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $111.86 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $64.15 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $48.95 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Bianes Pack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.